This is the first publication of IBISWorld's Pharmaceutical Product Manufacturing in Australia Industry Risk Ratings Report.

Industry Risk Ratings Synopsis

This Industry Risk Ratings report is a detailed analysis of all risks related to the Pharmaceutical Product Manufacturing in Australia market . Our analyst consider Industry Risk to be 'the difficulty of the business immediate environment' .

The report analyses all risk related to the industry operations . Our analysts are looking at 3 kind of risks : Structural risks are risks related to the industry itself, Growth Risks are risks related to the expected growth and performance of the industry and External Risks are risks or threats coming from external forces .

This approach is new in that it analyses non-financial information surrounding each market . We are using score-cards to analyse the intensity of each risk within the industry, where 1 is the lowest intensity and 9 the highest . The Market Risk score measures expected Market Risk over the coming 12-18 months.

Market Definition

The Pharmaceutical Product Manufacturing market comprises industry players that manufacture various medicinal and pharmaceutical products, including drugs, medicines (including herbal medicines), medicinal chemicals as well as nappies and feminine hygiene products. Market products are then either distributed by the manufacturer or via wholesalers to hospitals, pharmacies and other retail outlets such as supermarkets.

What Will You Find In This Report?

Risk Overview

The Risk Overview chapter includes sections on Market Definition and Activities, Market Risk Score and Risk Rating Analysis. The Market Definition and Activities section provides a detailed definition of the activities carried out by operators in this market as defined in NAICS. A list of the primary activities of the market is also included. The Market Risk Score section provides the Overall Market Risk Score as well as the Risk Scores for each of the three types of risk covered that combine to form the Overall Market Risk Score. These three types of risk are Structural Risk, Growth Risk and External Sensitivity Risk. The Risk Rating Analysis section discusses the underlying factors contributing to the Overall Market Risk Score.

Structural Risk

The Structural Risk chapter looks at risk arising from within the market itself and provides a detailed discussion of the market ’s level of exposure to seven key figures . These key figures are Barriers to Entry, Competition, Market Exports, Market Imports, Level of Assistance, Industry Status Stage and Volatility of Market . The Overall Structural Risk Score is a weighted aggregation of these seven key figures . Each of the key figures is discussed in detail in this section.

Growth Risk

The Growth Risk chapter looks at risks arising from the expected future performance of the market . The Overall Growth Risk Score is determined by amalgamating the scores for Recent Market Growth and Projection Market Growth. Detailed analysis is provided discussing the reasons for the growth scores of both.

Sensitivity Risk

The Sensitivity Risk chapter looks at risks arising from forces (sensitivities) external to the market . The Overall External Sensitivity Risk Score is determined by identifying the most significant (up to 6) external factors and weighting them to represent how significant each sensitivity is to the performance of the market . Examples of External Sensitivities are Exchange Rates, Interest Rates, Commodity Prices and Government Regulations. There is also a in-depth overview of the affect each of the sensitivities has on the market, including charts and data tables where appropriate.

Industry Risk and Market Risk Scoring Methodology

This chapter provides an overview of how IBISWorld defines Market Risk and discusses the methodology used to arrive at an Market Risk Score. There is also a table that provides a definition of the seven levels of Market Risk.

C2543 - Pharmaceutical Product Manufacturing in Australia
F4523 - Chemical Wholesaling in Australia
O8611 - General Hospitals in Australia
G5111 - Supermarkets and Other Grocery Stores in Australia
F4797 - Pharmaceuticals Wholesaling in Australia
G525a - Pharmacies in Australia
G525b - Cosmetic and Toiletry Retailing in Australia

Table Of Contents

RISK OVERVIEW

Industry Definition and Activities
Industry Risk Score
Risk Rating Analysis

STRUCTURAL RISK

Barriers to Entry
Competitive Landscape
Domestic and International Demand
Industry Support
Life Cycle
Industry Volatility

GROWTH RISK

Recent Growth Analysis
Forecast Growth Analysis

SENSITIVITY RISK

Population aged 55 or older
Health consciousness
Federal funding for the Pharmaceutical Benefits Scheme
Downstream demand from agriculture
Systems and technology for medicinal and pharmaceutical product manufacturing
Legislative compliance requirements for pharmaceutical product manufacturing

INDUSTRY RISK AND INDUSTRY RISK SCORING METHODOLOGY

What is Market Risk?
The Market Risk Scoring Methodology
Risk Rating Score Definition

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Pharmacy Compounding Systems/Devices - Medical Device Safety and Approval Report - Comprehensive

Pharmacy Compounding Systems/Devices - Medical Device Safety and Approval Report - Comprehensive

  • $ 99
  • Industry report
  • April 2014
  • by DeviceMatters

The comprehensive DeviceMatters medical device safety and approval report provides an overview of Pharmacy Compounding Systems/Devices, recent device approvals, supplements, recalls, and in-depth review ...

Pharmacy Automation: Technologies and Global Markets

Pharmacy Automation: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • March 2014
  • by BCC Research

REPORT HIGHLIGHTS The global pharmacy automation market reached nearly $3.0 billion in 2012. This market is expected to grow to nearly $3.2 billion in 2013 and $4.9 billion in 2018 with a compound annual ...

2014 Worldwide Pharmacies & Drug Stores Industry-Industry & Market Report

2014 Worldwide Pharmacies & Drug Stores Industry-Industry & Market Report

  • $ 299
  • Industry report
  • December 2013
  • by Barnes Reports

The 2014 Worldwide Pharmacies & Drug Stores Industry-Industry & Market Report, published annually by Barnes Reports, contains timely and accurate industry statistics, forecasts and demographics. NEW fo ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.